Cite
Mohzari YA, Alshuraim R, Asdaq SMB, et al. Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. J Infect Public Health. 2021;15(1):1-6doi: 10.1016/j.jiph.2021.11.006.
Mohzari, Y. A., Alshuraim, R., Asdaq, S. M. B., Aljobair, F., Alrashed, A., Alsowaida, Y. S., Alamer, A., Al Munjem, M. F., Al Musawa, M. I., Hatata, M., Alzaaqi, M. A., Binrokan, A., Alajlan, S. A., Abraham, I., & Alamer, A. (2021). Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. Journal of infection and public health, 15(1), 1-6. https://doi.org/10.1016/j.jiph.2021.11.006
Mohzari, Yahya A, et al. "Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis." Journal of infection and public health vol. 15,1 (2021): 1-6. doi: https://doi.org/10.1016/j.jiph.2021.11.006
Mohzari YA, Alshuraim R, Asdaq SMB, Aljobair F, Alrashed A, Alsowaida YS, Alamer A, Al Munjem MF, Al Musawa MI, Hatata M, Alzaaqi MA, Binrokan A, Alajlan SA, Abraham I, Alamer A. Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. J Infect Public Health. 2021 Nov 17;15(1):1-6. doi: 10.1016/j.jiph.2021.11.006. Epub 2021 Nov 17. PMID: 34852307.
Copy
Download .nbib